Plain-English translation of NCT05582551 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new system called HPARSS that helps doctors identify which young cancer survivors are at risk for sensory problems—like hearing loss, vision problems, or nerve damage—based on the specific cancer treatments they received. The goal is to catch these problems early by making sure at-risk patients get proper screening and testing in their regular cancer follow-up appointments.
Many young cancer survivors develop sensory problems from their treatment, but these problems are often missed or diagnosed late because doctors don't have a clear way to know which patients are at highest risk. This study aims to solve that problem by creating a tool that flags at-risk patients so their doctors can screen them promptly.
You likely qualify if…
You likely don't qualify if…
If you qualify, your cancer doctor will identify you as at-risk for sensory problems using the new screening tool. You and your parent or guardian will be invited to participate. You'll complete sensory screening tests during a regular clinic visit—these might include hearing tests, vision tests, or nerve function tests depending on your specific treatment history. If any screening results suggest you need further testing or therapy, your doctor will schedule those appointments for you.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States